Hyperlipidaemia
Seiten
2012
Oxford University Press (Verlag)
978-0-19-954350-2 (ISBN)
Oxford University Press (Verlag)
978-0-19-954350-2 (ISBN)
In the last 10 years the understanding of hyperlipidaemia has advanced greatly. This pocketbook provides a practical approach to therapy, addresses common clinical problems and looks to the future of treatment for the condition, focusing on new therapeutic targets. In essence it translates clinical trial science into everyday clinical practice.
In the last decade, advances in the understanding of lipoprotein and lipid metabolism have developed enormously. This has resulted in a detailed knowledge of the mechanisms underlying the primary and secondary dyslipidaemias. Furthermore, the role of lipoproteins in atherogenesis is increasingly understood at the cellular and molecular level.
In this book, the scale of the problem of cardiovascular disease (CVD) is described together with the possibilities for prevention. The pathophysiology of lipid and lipoproteins provide a background to the understanding of the primary and secondary dyslipidaemias and the mechanism of action of the different drug classes.
A practical approach to therapy is provided including diet, lifestyle, and therapeutic approaches. Common clinical problems are addressed and the book looks to the future, principally in relation to new therapeutic targets. This book provides the basis for the translation of clinical trial science into everyday clinical practice for the benefit of the individual patient.
In the last decade, advances in the understanding of lipoprotein and lipid metabolism have developed enormously. This has resulted in a detailed knowledge of the mechanisms underlying the primary and secondary dyslipidaemias. Furthermore, the role of lipoproteins in atherogenesis is increasingly understood at the cellular and molecular level.
In this book, the scale of the problem of cardiovascular disease (CVD) is described together with the possibilities for prevention. The pathophysiology of lipid and lipoproteins provide a background to the understanding of the primary and secondary dyslipidaemias and the mechanism of action of the different drug classes.
A practical approach to therapy is provided including diet, lifestyle, and therapeutic approaches. Common clinical problems are addressed and the book looks to the future, principally in relation to new therapeutic targets. This book provides the basis for the translation of clinical trial science into everyday clinical practice for the benefit of the individual patient.
John Betteridge is Professor of of Endrocrinology and Metabolism at University College, London UK.
1. Epidemiology of cardiovascular disease: the scale of the problem ; 2. Lipids, lipoproteins and atherogenesis ; 3. Risk estimation systems in clinical use: SCORE, HeartScore, Framingham, PROCAM, ASSIGN and QRISK ; 4. Primary dyslipidaemias ; 5. Secondary dyslipidemias ; 6. Diet and lifestyle ; 7. Pharmacological therapy: Statins ; 8. Pharmacological therapy: Non-Statin Drugs ; 9. Combination therapy for the management of hyperlipidaemia ; 10. Recent lipid-lowering trials in perspective: Implications for therapy ; 11. Vascular imaging ; 12. Common problems in lipid management
| Reihe/Serie | Oxford Cardiology Library |
|---|---|
| Zusatzinfo | 2-colour line drawings and halftones throughout |
| Verlagsort | Oxford |
| Sprache | englisch |
| Maße | 101 x 180 mm |
| Gewicht | 146 g |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Gastroenterologie |
| Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie | |
| ISBN-10 | 0-19-954350-X / 019954350X |
| ISBN-13 | 978-0-19-954350-2 / 9780199543502 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 76,00
